Logo
Home
About
Articles
FAQ
Sign In
Search
Join the mailing list
Logo
Search
Home
About
Articles
FAQ
Sign In
Join the mailing list
Analysis

Roundup: Testing Healthcare AI in Space, Increasing Statin Adoption, Epic's move into Scribing, etc

Plus Peloton's surprise profit, 4 Questions with the CSO of Solera Health and a hot-take on AI driven automation.

Christina Farr, +1
Aug 14, 2025
Roundup: Testing Healthcare AI in Space, Increasing Statin Adoption, Epic's move into Scribing, etc

How healthcare VC firms are thinking about longevity

7wire shared their thesis and market map with us that it created for its own LPs

Christina Farr
Jul 2, 2025
How healthcare VC firms are thinking about longevity

Is your women's health business venture backable?

Part 1 in our founder's guide to financing your women's health startup

Leslie Schrock, +1
Apr 15, 2025
Is your women's health business venture backable?

23andMe should have raised less capital

My takeaway from today’s news that the company is filing for bankruptcy

Christina Farr
Mar 24, 2025
Paid
23andMe should have raised less capital

What happened to the digital health unicorns of 2020 to 2022?

Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!

Halle Tecco
Mar 21, 2025
Paid
What happened to the digital health unicorns of 2020 to 2022?

Why is longevity suddenly so hot?

Between Function Health, Lifeforce and Superpower, this space is on fire

Christina Farr
Mar 17, 2025
Paid
Why is longevity suddenly so hot?

How are employers going to pay for cell and gene therapies?

Let’s get real about the alliance between U.S. health care and employment

Christina Farr
Jan 20, 2025
How are employers going to pay for cell and gene therapies?

Interested in sponsoring Second Opinion?
Reach out!

I consent to receive newsletters via email. Terms of use and Privacy policy.